Titel

Merkliste
1 Ergebnisse

Supplementary Figure 2: Resource title*Palbociclib versus a..:

Ernest Law (4955032) ; Roya Gavanji (11668177) ; Sarah Walsh (8943155)...
https://figshare.com/articles/figure/Supplementary_Figure_2_Resource_title_Palbociclib_versus_abemaciclib_in_HR_HER2-_advanced_breast_cancer_an_indirect_comparison_of_patient-reported_end_points_docx/16964941. , 2021

Link: https://doi.org/10.25402/cer.16964941.v1

RT Journal
T1 <Title>Supplementary Figure 2: Resource title*Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points.docx</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16964941&Exemplar=1&LAN=DE
				
A1 Ernest Law (4955032)
A1 Roya Gavanji (11668177)
A1 Sarah Walsh (8943155)
A1 Anja Haltner (8631228)
A1 Rebecca McTavish (11668180)
A1 Chris Cameron (696037)
YR 2021
K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
K1 Abemaciclib
K1 advanced breast cancer
K1 health-related quality of life
K1 HER2-negative
K1 hormone receptor-positive
K1 indirect treatment comparison
K1 matching-adjusted indirect comparison
K1 Palbociclib
K1 patient-reported outcomes
K1 quality of life
JF https://figshare.com/articles/figure/Supplementary_Figure_2_Resource_title_Palbociclib_versus_abemaciclib_in_HR_HER2-_advanced_breast_cancer_an_indirect_comparison_of_patient-reported_end_points_docx/16964941
LK http://dx.doi.org/https://doi.org/10.25402/cer.16964941.v1
DO https://doi.org/10.25402/cer.16964941.v1
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)